What is the Aptus Pharma IPO price band and lot size?

Aptus Pharma IPO is priced at ₹65 – ₹70 per share with a lot size of 2000 shares, so the minimum application is ₹1,40,000.

What was the Aptus Pharma IPO listing gain?

Aptus Pharma IPO listed on 30 Sept 2025 at ₹81, +15.4% against its issue price of ₹70. That is the price it opened at on debut; it trades at ₹472 today, +1586.1% since issue.

How much was Aptus Pharma IPO subscribed?

Aptus Pharma IPO was subscribed 22× in total across both exchanges.

How have IPOs like Aptus Pharma IPO performed?

Of the 267 SME issues that listed in 2025 and that MarketPing can price, the median return since issue price is −9.7% and 54.3% trade below their issue price. This is a base rate for the cohort, not a forecast for this issue.

ListedSMEPharmaceuticals & DrugsAPPL

Aptus Pharma IPO

Aptus Pharma IPO is an SME IPO raising ₹13 Cr at ₹65 – ₹70 a share. It listed on 30 Sept 2025 at ₹81, +15.4% against its issue price of ₹70, and trades at ₹472 today (+1586.1% since issue, after adjusting for bonus issues or splits: one share allotted at the IPO is now 2.5 shares). It was subscribed 22× in total.

Get alerts on this company Company page Prospectus ↗

₹70

Issue price

₹472

Price now

+1586.1%

Since issue price

30 Sept 2025

Listed on

22×Subscribed (final) · all exchanges

22.2 times more demand than shares on offer

populated partly populated we hold nothing here — the tab says why

How its cohort has done

267 SME issues listed in 2025 that we can price today. This is the group this issue belongs to.

−9.7%

Median return since issue price

54.3%

Now trading below their issue price

Neither figure is a forecast for this issue — they describe what happened to comparable issues. Full cohort analytics →

What we hold for this issue

Stated up front on every issue, so a sparse page reads as a fact about the source rather than a broken one.

Category split — who bidNot available from NSE for this issue

How demand built over timeFinal figure held, but no series — we were not sampling this issue while it was live

Price-point demand curveLive only — NSE stops serving this once bidding closes

Lead managers and registrarNot published — smaller SME issues often name none

Official documents1 document

Listing-day priceOpened at ₹81 on debut

Performance since listingComputed from our own daily closes, adjusted for bonus issues or splits (one IPO share is now 2.5)

What happens when

22 SeptPre-apply

23 SeptBidding opens

25 SeptBidding closes

29 SeptAllotment

29 SeptRefunds

30 SeptListing

6 NovMandate ends

Track Aptus Pharma Limited

Results, orders, board decisions and every other filing — summarised and sent to your WhatsApp the minute they are out.

Open the company page

Figures are as published by the exchanges and the issuer’s prospectus. MarketPing publishes facts, comparisons and history only — nothing here is a recommendation to apply to this issue, and we do not publish grey market premium.